An increasing number of therapies obtain designations with accelerated and priority reviews. The need to streamline the pathway from development to commercialization path for these drug products is of crucial importance. Lonza will share practical Chemistry, Manufacturing, and Controls (CMC) experience on how to navigate regulatory, development, manufacturing and packaging requirements critical for accelerated clinical pathways and commercialization. To learn more, watch our on-demand webinar.
You may also be interested in:
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center